PMCPA Case Analysis

Over 2,000 real rulings β€” analysed for what they mean to your team. Published every day.

All Cases PMCPA Case of the Week PMCPA Cases

Showing 1914 cases

2018
CASE
AUTH/3117/11/18 Seqirus

AUTH/3117/11/18: Director v Seqirus (Clinical trial disclosure) – Outwith scope of the Code

PMCPA case AUTH/3117/11/18 (Director v Seqirus) concerned clinical trial disclosure but was ruled outwith the scope of the ABPI Code (2016). No…

2018
CASE
AUTH/3097/9/18 Teva

AUTH/3097/9/18: Director v Teva β€” Clinical trial disclosure on EUCTR (No breach after appeal)

BMJ analysis suggested Teva had unreported EUCTR trial results (72% disclosed). Panel initially found Clause 9.1 breaches for two UK-nexus trials, but…

2012
CASE
AUTH/2516/6/12 Merz Pharma UK

AUTH/2516/6/12: Allergan/PMCPA Director v Merz β€” Bocouture ad implied 1:1 interchangeability with Botox (breach of undertaking)

Merz’s Bocouture ad in Cosmetic News implied 1:1 clinical conversion/equal potency vs Botox. PMCPA ruled it breached a prior undertaking and failed…

2012
CASE
AUTH/2494/3/12 Galen ⭐ Case of the Week

AUTH/2494/3/12: Norgine v Galen β€” Trustsaver cost-savings campaign (No breach)

Norgine challenged Galen’s Trustsaver website, leavepiece and ads for allegedly misleading NHS cost-savings claims based on 100% switching. The PMCPA Panel found…

2012
CASE
AUTH/2471/1/12 Sanofi

AUTH/2471/1/12: Anonymous v Sanofi β€” Restaurant meeting seen as Christmas social event; inadequate controls over third‑party arrangements

Sanofi co-sponsored a December 2011 restaurant meeting. Lack of written documentation, limited educational content and β€œChristmas party” impression led to breaches of…

2010
CASE
AUTH/2327/6/10 GrΓΌnenthal

MHRA v GrΓΌnenthal: pre-licence β€œsoftening the market” for tapentadol via HELMs (AUTH/2327/6/10)

MHRA raised concerns that GrΓΌnenthal promoted unlicensed tapentadol via HELMs’ formulary mapping and briefings. PMCPA found pre-authorisation promotion and ruled breaches of…

2013
CASE
AUTH/2577/2/13 AbbVie

AbbVie voluntary admission: out-of-date Humira prescribing information used in UK online banner and journal ads (AUTH/2577/2/13)

AbbVie admitted Humira ads (UK website banner and UK-based journals) used outdated prescribing information (May 2011) instead of the Dec 2012 version.…

2012
CASE
AUTH/2552/11/12 Ferring

Ferring: ISU urology meeting in Belfastβ€”5-star venue, golf and gala dinner created an unacceptable impression (AUTH/2552/11/12)

Anonymous NHS HCPs complained about excessive hospitality at an ISU meeting in Belfast. Despite mainly exhibiting, the programme and 5-star venue created…

2013
CASE
AUTH/2595/4/13 Eli Lilly ⭐ Case of the Week

AUTH/2595/4/13: Pharmacist v Lilly β€” Not stated

PMCPA case summary for AUTH/2595/4/13 (Pharmacist v Lilly). The provided case text contains no details of the complaint, outcome, clauses, or sanctions.

2013
CASE
AUTH/2574/2/13 Sanofi

AUTH/2574/2/13: Pharmacist v Sanofi Pasteur MSD – Zostavax email emphasising surgery profit

A rep emailed a GP practice about Zostavax supply, highlighting β€œΒ£26 per dose profit” and providing a patient-invite template. No breach for…

2013
CASE
AUTH/2625/8/13 Sanofi

AUTH/2625/8/13: Anonymous v Sanofi β€” conduct of a representative (no breach)

Anonymous complaint alleged a Sanofi representative was rude and swore at a hospital visit. Sanofi said the named person had left and…

2012
CASE
AUTH/2570/12/12 Napp Pharmaceuticals

AUTH/2570/12/12: GSK v Napp β€” Flutiform leavepieces found misleading on comparability and cost-effectiveness claims

GSK challenged two Napp Flutiform leavepieces comparing to Seretide. PMCPA ruled multiple breaches for unqualified β€œcomparable clinical efficacy”, substitution messaging and broad…

2013
CASE
AUTH/2682/11/13 Merck Serono

Merck Serono: premium economy flights and β€œparty atmosphere” riverboat event led to hospitality breaches (AUTH/2682/11/13)

Anonymous complaint about hospitality at ASRM (Boston) and ESHRE (London). PMCPA found breaches for non-economy flights, an expensive steakhouse dinner, and staff…

2015
CASE
AUTH/2810/12/15 Teva ⭐ Case of the Week

Teva breached ABPI Code over β€˜intuitive’ inhaler ad for DuoResp Spiromax (AUTH/2810/12/15)

Teva’s DuoResp Spiromax ad claimed patients would know how to use the inhaler immediately. The PMCPA ruled the β€˜intuitive’ claims misleading and…

2015
CASE
AUTH/2790/8/15 Chugai

AUTH/2790/8/15: Anonymous, non-contactable ex-employee v Chugai β€” consultancy arrangements (no breach after appeal)

Anonymous ex-employee ΠΏΠΎΠ²Ρ‚ΠΎΡ€ed a prior consultancy complaint but provided no evidence. Panel initially referenced an earlier Clause 9.1 breach, but the Appeal…

Ask questions about any PMCPA case

Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases β€” ask about precedents, clauses, and how they apply to your situation.

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training